Chiesi USA, Inc.
Chiesi is a global biopharmaceutical group committed to research and development of innovative therapeutic solutions in respiratory health, rare diseases, and specialized care. As a Benefit Corporation and B Corp certified since 2019, Chiesi emphasizes sustainability, social impact, and environmental responsibility, aiming for net zero emissions by 2035. With over 85 years of experience, the company operates in 31 countries with more than 6,500 employees, and invests heavily in research, innovation, and sustainable practices.
Industries
Nr. of Employees
Very Large (1000+)
Chiesi USA, Inc.
Products
Formoterol fumarate inhalation product
Inhaled bronchodilator formulation using formoterol fumarate; the product page references national prescribing information and regulatory summaries.
Inhaled tobramycin formulation
Inhaled antibiotic formulation using tobramycin for respiratory indications; product page links to regulatory summaries.
Pulmonary surfactant product (neonatology)
Exogenous pulmonary surfactant therapy used in neonatal respiratory distress management; product and clinical information are available via neonatal care pages.
Bronchitol (inhaled therapy product)
Product page referencing the national product monograph for up-to-date prescribing information; site advises contacting a healthcare professional for medical questions.
Formoterol fumarate inhalation product
Inhaled bronchodilator formulation using formoterol fumarate; the product page references national prescribing information and regulatory summaries.
Inhaled tobramycin formulation
Inhaled antibiotic formulation using tobramycin for respiratory indications; product page links to regulatory summaries.
Pulmonary surfactant product (neonatology)
Exogenous pulmonary surfactant therapy used in neonatal respiratory distress management; product and clinical information are available via neonatal care pages.
Bronchitol (inhaled therapy product)
Product page referencing the national product monograph for up-to-date prescribing information; site advises contacting a healthcare professional for medical questions.
Services
Pharmacovigilance reporting service
Adverse-event intake and regulatory reporting channel for suspected drug reactions.
Medical information provision
Provision of regulated product and therapeutic information for clinicians and patients through controlled channels.
Clinical development and trial management
End-to-end clinical study services including protocol development, multi-phase trial execution, data transparency and decentralized trial components.
Biologics development and GMP manufacturing services
Integrated development and GMP manufacturing services for biologics, covering cell cultivation, upstream processing (250–2000 L), downstream processing, sterile fill–finish, packaging and small‑batch production for clinical and niche indications.
Partnering and open innovation programs
Structured partnering offerings for co-development, licensing and open-innovation collaborations, including digital-health partnerships.
Global commercialization and market access operations
Commercial and market access capabilities across multiple countries supported by a network of international affiliates.
Pharmacovigilance reporting service
Adverse-event intake and regulatory reporting channel for suspected drug reactions.
Medical information provision
Provision of regulated product and therapeutic information for clinicians and patients through controlled channels.
Clinical development and trial management
End-to-end clinical study services including protocol development, multi-phase trial execution, data transparency and decentralized trial components.
Biologics development and GMP manufacturing services
Integrated development and GMP manufacturing services for biologics, covering cell cultivation, upstream processing (250–2000 L), downstream processing, sterile fill–finish, packaging and small‑batch production for clinical and niche indications.
Partnering and open innovation programs
Structured partnering offerings for co-development, licensing and open-innovation collaborations, including digital-health partnerships.
Global commercialization and market access operations
Commercial and market access capabilities across multiple countries supported by a network of international affiliates.
Expertise Areas
- Clinical trial management and decentralized trials
- Biologics discovery, development and translational R&D
- GMP biomanufacturing with downstream fill–finish and packaging
- Respiratory therapeutics and inhalation drug/device engineering
Key Technologies
- Monoclonal antibody and recombinant protein development
- Upstream bioprocessing (250–2000 L scale)
- Flexible small-batch biologics manufacturing
- Sterile fill–finish and packaging processes